Hansen Medical, Inc.  

(Public, NASDAQ:HNSN)   Watch this stock  
Find more results for hnsn
1.20
+0.03 (2.56%)
Real-time:   10:40AM EDT
NASDAQ real-time data - Disclaimer
Currency in USD
Range 1.16 - 1.21
52 week 1.10 - 2.89
Open 1.16
Vol / Avg. 25,315.00/204,083.00
Mkt cap 134.64M
P/E     -
Div/yield     -
EPS -0.53
Shares 112.20M
Beta 1.04
Inst. own 33%
Nov 4, 2014
Q3 2014 Hansen Medical Inc Earnings Release (Estimated) - 4:00PM EST - Add to calendar
Jul 31, 2014
Q2 2014 Hansen Medical Inc Earnings Call - Webcast
Jul 31, 2014
Q2 2014 Hansen Medical Inc Earnings Release
More events from DailyFinance »    

Key stats and ratios

Q2 (Jun '14) 2013
Net profit margin -178.45% -328.12%
Operating margin -160.49% -299.36%
EBITD margin - -244.11%
Return on average assets -85.14% -88.98%
Return on average equity -395.55% -267.80%
Employees 171 -
CDP Score - -

Address

800 East Middlefield Road
MOUNTAIN VIEW, CA 94043
United States - Map
+1-650-4045800 (Phone)
+1-650-4045901 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

Hansen Medical, Inc. develops, manufactures and markets a generation of medical robotics designed for accurate positioning, manipulation and stable control of catheters and catheter-based technologies. The Company�s products include Sensei Robotic Catheter System, or Sensei system, Magellan Robotic System, Artisan Control Catheter, or Artisan catheter, Lynx Robotic Ablation Catheter, or Lynx catheter and CoHesion 3D Visualization Module, or CoHesion Module. During the year ended December 31, 2011, the Company had shipped a total of 109 Sensei systems, of which 63 were shipped in the United States and 46 were shipped to the rest of the world. During 2011, it had recognized revenue on a total of 103 of these Sensei systems. As of December 31, 2011, it had shipped one Magellan Robotic System in Europe and one vascular research system in the United States. As of December 31, 2011, 76 Sensei systems the Company had shipped were configured with the CoHesion Module.

Officers and directors

Michael L. Eagle Lead Independent Chairman of the Board
Age: 66
Bio & Compensation  - Reuters
Cary Vance President, Chief Executive Officer, Director
Age: 48
Bio & Compensation  - Reuters
Christopher P. Lowe Interim Chief Financial Officer, Director
Age: 46
Bio & Compensation  - Reuters
William Sutton Chief Operating Officer
Age: 49
Bio & Compensation  - Reuters
Robert O. Cathcart Senior Vice President - Global Sales
Age: 54
Bio & Compensation  - Reuters
Joseph Guido Vice President - Marketing and Business Development
Age: 48
Bio & Compensation  - Reuters
Susan Leonard Vice President - Human Resources
Age: 51
Bio & Compensation  - Reuters
Rita V. Jacob Vice President - Clinical Affairs and Training
Age: 54
Bio & Compensation  - Reuters
Marjorie L. Bowen Independent Director
Age: 49
Bio & Compensation  - Reuters
Kevin Hykes Independent Director
Age: 48
Bio & Compensation  - Reuters